sarkosyl has been researched along with Neuroblastoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, J; Craige, CP; Lauretti, E; Praticò, D | 1 |
| Gabizon, R; Gahali, I; Meiner, Z; Taraboulos, A; Yanai, A | 1 |
2 other study(ies) available for sarkosyl and Neuroblastoma
| Article | Year |
|---|---|
Pharmacological modulation of GSAP reduces amyloid-β levels and tau phosphorylation in a mouse model of Alzheimer's disease with plaques and tangles.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Benzamides; Cell Line, Tumor; Disease Models, Animal; Enzyme Inhibitors; Humans; Imatinib Mesylate; Mice; Mice, Transgenic; Mutation; Neuroblastoma; Peptide Fragments; Phosphorylation; Piperazines; Plaque, Amyloid; Presenilin-1; Proteins; Pyrimidines; Sarcosine; Statistics, Nonparametric; tau Proteins | 2014 |
Subcellular trafficking abnormalities of a prion protein with a disrupted disulfide loop.
Topics: Animals; CHO Cells; Cricetinae; Disulfides; Endopeptidase K; Fluorescent Antibody Technique; Hexosaminidases; Mice; Mutation; Neuroblastoma; Protein Conformation; PrPC Proteins; PrPSc Proteins; Sarcosine; Scrapie; Solubility; Tumor Cells, Cultured | 1999 |